Jump Financial’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
Jump Financial's CATX Position: Q3 2026 in Review
Jump Financial reduced its Perspective Therapeutics (CATX) stake by 81% in Q3 2026, selling an estimated $150K and leaving 11,841 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.
Jump Financial first reported a position in CATX in Q4 2024 and has held it in 3 quarters since. The position peaked at $688K in Q4 2024. 118 funds tracked by Wall St. Rank hold CATX as of Q3 2026.
- Jump Financial held 11,841 shares of Perspective Therapeutics worth $32.6K as of Q3 2026.
- Jump Financial sold 49,359 Perspective Therapeutics shares in Q3 2026, an estimated $150K.
- Perspective Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2251 holding.
- Jump Financial first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 3 quarters since.
- Jump Financial's Perspective Therapeutics position peaked at $688K in Q4 2024.
- 118 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.